Quantitative Proteomic profiling identifies protein correlates to EGFR kinase inhibition

Clinical oncology is hampered by a lack of tools to accurately assess a patient’s response to pathway-targeted therapies. Serum and tumor cell surface proteins whose abundance, or change in abundance in response to therapy, differentiates patients responding to a therapy from patients not-responding...

詳細記述

保存先:
書誌詳細
主要な著者: Kani, Kian, Faca, Vitor M., Hughes, Lindsey D., Zhang, Wenxuan, Fang, Qiaojun, Shahbaba, Babak, Luethy, Roland, Erde, Jonathan, Schmidt, Joanna, Pitteri, Sharon J., Zhang, Qing, Katz, Jonathan E., Gross, Mitchell E., Plevritis, Sylvia K., McIntosh, Martin W., Jain, Anjali, Hanash, Sam, Agus, David B., Mallick, Parag
フォーマット: Artigo
言語:Inglês
出版事項: 2012
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3959865/
https://ncbi.nlm.nih.gov/pubmed/22411897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-11-0852
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料